肝脏成像报告和数据系统对比增强 美国非辐射治疗反应评估版本 2024
Andrej Lyshchik1, David T Fetzer1, Yuko Kono1
1From the Department of Radiology, Thomas Jefferson University Hospital, 132 S 10th St, 763G Main Bldg, Philadelphia, PA 19107 (A.L.); Department of Radiology, UT Southwestern Medical Center, Dallas, Tex (D.T.F.); Departments of Medicine and Radiology, University of California, San Diego, San Diego, Calif (Y.K.); Department of Diagnostic Imaging, University of Calgary, Calgary, Alberta, Canada (S.R.W.); Department of General Internal Medicine, Hirslanden Klinik Beau-Site, Hirslanden Salem-Spital, and Hirslanden Klinik Permanence, Bern, Switzerland (C.F.D.); Interdisciplinary Ultrasound Center, Department of Radiology, LMU University Hospital, Ludwig Maximilian University of Munich, Munich, Germany (D.A.C.); Department of Interventional Ultrasound, Casa di Cura Igea, Milan, Italy (M.F.M.); Joint Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada (H.J.J., T.K.K.); Department of Radiology and Institute of Radiation Medicine, Seoul National University Hospital, Seoul, Korea (J.M.L.); Department of Radiology, Seoul National University College of Medicine, Seoul, Korea (J.M.L.); Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osaka, Japan (Y.M., M.K.); Hepatobiliary and Immunoallergic Diseases, Division of Internal Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (F.P.); and Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy (F.P.).
更新的LI-RADS CEUS Nonradiation TRA v2024标准化了对比度增强超声波,用于评估肝细胞癌治疗反应. 它精细化了标准,以准确区分可行的瘤和治疗后的变化,改善HCC管理.
科学领域:
- 放射学 放射学是一门学科.
- 肝胆道成像 肝胆道成像
- 在瘤学瘤学.
背景情况:
- 美国放射学学院肝脏成像报告和数据系统 (LI-RADS) 对于标准化肝细胞癌 (HCC) 诊断和管理至关重要.
- 目前LI-RADS包括CT/MRI的监测,诊断 (CT,MRI,CEUS) 和治疗反应评估 (TRA).
- 扩展包括CEUS TRA用于非辐射疗法是最近的一项进展.
研究的目的:
- 为了提供LI-RADS CEUS Nonradiation TRA v2024的概述.
- 详细介绍使用CEUS的成像研究结果,技术和评估治疗后瘤生存能力的标准.
- 概述了用于分配LI-RADS治疗反应类别的更新算法.
主要方法:
- 对LI-RADS CEUS Nonradiation TRA v2024指南进行审查和综合.
- 描述CEUS成像检测结果,具体针对可活性瘤和治疗后的变化.
- 解释内损伤和内损伤增强的不同诊断标准.
主要成果:
- LI-RADS CEUS 非辐射 TRA v2024 包含了针对 CEUS 生存瘤的出现和治疗后变化的具体考虑.
- 承认治疗后的反应性变化可以模仿可行的瘤,由于没有洗的危机增强.
- 采用更广泛的内和更严格的内增强标准来提高准确性.
结论:
- 在v2024更新中,对HCC中非辐射TRA的CEUS标准进行了改进.
- 在将可活性瘤与反应性变化区分的准确性提高.
- 为了更好地管理患者,TRA算法分配了标准化的LR-TR类别 (不可行,模两可,可行).
更多相关视频
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Ultrasound I: Abdominal Ultrasonography
Abdominal ultrasonography, commonly known as abdominal ultrasound, is a vital, non-invasive medical imaging technique widely used in healthcare.
Procedure:
This diagnostic tool allows the clinician to visually inspect internal structures within the abdomen, including vital organs such as the liver, gallbladder, pancreas, kidneys, and spleen.
The abdominal ultrasound process begins with applying a special gel to the patient's skin over the abdomen. This gel enhances the...
